azathioprine has been researched along with Biliary or Urinary Stones in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, disease relapse is common in long-term follow-up, despite a successful initial treatment response." | 1.48 | Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment. ( Cho, DH; Jun, JH; Kim, MH; Lee, HW; Lee, SK; Lee, SS; Moon, SH; Nam, K; Park, DH; Seo, DW; Song, TJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HW | 1 |
| Moon, SH | 1 |
| Kim, MH | 1 |
| Cho, DH | 1 |
| Jun, JH | 1 |
| Nam, K | 1 |
| Song, TJ | 1 |
| Park, DH | 1 |
| Lee, SS | 1 |
| Seo, DW | 1 |
| Lee, SK | 1 |
1 other study available for azathioprine and Biliary or Urinary Stones
| Article | Year |
|---|---|
Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Bile Duct Diseases; Calculi; Exoc | 2018 |